SURG Surgepays Inc
Company Analysis
Latest News
🟢 Surgepays is trading 12% up with no confirmed catalyst
Surgepays is trading 12.08% up at $0.14 on October 22, 2026; no confirmed company-specific announcement explaining the move was found in available coverage. -...
🟢 Surgepays is trading 5.2% up — reason remains unclear
Surgepays is trading 5.17% up at $0.13 on October 22, 2026; no confirmed company-specific catalyst has been identified, and the reason for the gain remains...
🟢 Surgepays is trading 6.44% up in pre-market with no confirmed catalyst
Surgepays is trading at $0.13, up 6.44% in pre-market; no confirmed driver has been identified. - No new company-specific announcement explaining the...
🟢 Surgepays is trading 5.6% up in after-hours trading
Surgepays is trading at $0.13, up 5.64% in after-hours trading on October 21, 2026; no new company-specific announcement surfaced to explain the move. -...
🔴 Surgepays is trading 5.8% down; reason remains unclear
Surgepays is trading at $0.12, down 5.83%, and the reason for the October 19 decline remains unclear. - No fresh company-specific announcement explaining the...
🔴 Surgepays is trading 5.43% down with no clear catalyst identified
Surgepays is trading 5.43% lower at $0.12 on October 16, 2026, with no company-specific announcement found to explain the move. - Shares declined after...
🔴 Surgepays is trading 5.59% down in after-hours trading — decline remains unexplained
Surgepays is trading at $0.12 (-5.59%); the after-hours decline remains unexplained. - On October 15, Surgepays announced GrowthLine is open to partner...
🟢 Surgepays is trading 6% up
Surgepays is trading at $0.13, up 5.77%; available reporting does not clearly identify a reason for the gain. - On October 15, Surgepays announced GrowthLine...
🔴 Surgepays is trading 7.8% down today with no October 14 company-specific catalyst identified
Surgepays is trading at $0.12, with a -7.75% change; no October 14 company-specific catalyst was identified. - SurgePays’ investor-relations press-release...
🟢 Surgepays is trading 8.6% up in pre-market — catalyst remains unclear
Surgepays is trading at $0.14 (+8.61%) in pre-market; the reason for the October 14 move remains unclear. - No fresh company-specific announcement explaining...
🔴 Surgepays is trading 5.9% down
Surgepays is trading at $0.12, down 5.85%, with no new company-specific announcement identified to explain the October 13 decline. - Recent coverage points to...
🔴 Surgepays is trading 5.4% down in pre-market
Surgepays is trading at $0.12, down 5.38% in pre-market; no new company-specific announcement explaining the October 13 decline has been identified. - The...
🔴 Surgepays is trading 10% down
Surgepays is trading 10.01% down at $0.13 on October 12, 2026, with no clear company-specific announcement identified to explain the decline. - The broader...
🔴 Surgepays is trading 6% down
Surgepays is trading at $0.13, down -5.57%, with no clear company-specific explanation for the October 12 decline in available coverage. - Nasdaq lists a...
🟢 Surgepays is trading 5.72% up with no clear company-specific catalyst
Surgepays is trading 5.72% higher at $0.15 on October 6, 2026, with no clear company-specific announcement explaining the intraday gain. - The S&P 500, Nasdaq...
🔴 Surgepays is trading 5.4% down
Surgepays is trading at $0.14, down 5.37%, with no clear company-specific catalyst identified for the September 30 decline. - The company news listing shows...
🔴 Surgepays is trading 5.6% down in pre-market
Surgepays is trading at $0.14, down 5.57% in pre-market, with no clear catalyst identified. - No new company announcement or clear catalyst for the September...
SurgePays Dodges Delisting for Now, but Can a $0.15 Stock Really Climb to $1.00 in Six Months?
Shares shifted as SurgePays popped 11% to $0.15 on news that Nasdaq handed the micro-cap wireless and prepaid-services provider a second 180-day window —...
🟢 Surgepays is trading 11% up today after receiving a 180-day Nasdaq bid-price extension
Surgepays is trading at $0.15, up +11.01%, after receiving an additional 180 days to regain Nasdaq’s minimum-bid-price compliance. - The extension runs...
🟢 Surgepays is trading 6.3% up today after receiving a 180-day Nasdaq bid-price extension
Surgepays is trading 6.31% higher at $0.14 after announcing it received an additional 180 days, until March 22, 2027, to regain Nasdaq’s $1.00...